Minocycline affects cocaine sensitization in mice

Neuroscience Letters

Volumn 452, Issue 3, 2009, Pages 258-261

  Chen, Hu ^a   Uz, Tolga ^a   Manev, Hari ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Addiction; Behavior; Cocaine; Glutamate; Methamphetamine; Minocycline; Sensitization

Indexed keywords

COCAINE; MINOCYCLINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; COCAINE; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; MALE; MICE; MICE, INBRED C57BL; MINOCYCLINE; MOTOR ACTIVITY; TIME FACTORS;

EID: 60849100481     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.01.078     Document Type: Article

References (25)

1. Alano C.C., Kauppinen T.M., Valls A.V., and Swanson R.A. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 9685-9690
2. Bachtell R.K., Choi K.H., Simmons D.L., Falcon E., Monteggia L.M., Neve R.L., and Self D.W. Role of GluR1 expression in nucleus accumbens neurons in cocaine sensitization and cocaine-seeking behavior. Eur. J. Neurosci. 27 (2008) 2229-2240
3. Diguet E., Fernagut P.O., Wei X., Du Y., Rouland R., Gross C., Bezard E., and Tison F. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur. J. Neurosci. 12 (2004) 3266-3276
4. Fagan S.C., Edwards D.J., Borlongan C.V., Xu L., Arora A., Feuerstein G., and Hess D.C. Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp. Neurol. 186 (2004) 248-251
5. Fujita Y., Ishima T., Kunitachi S., Hagiwara H., Zhang L., Iyo M., and Hashimoto K. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 336-339
6. González J.C., Egea J., Del Carmen Godino M., Fernandez-Gomez F.J., Sánchez-Prieto J., Gandía L., García A.G., Jordán J., and Hernández-Guijo J.M. Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons. Eur. J. Neurosci. 26 (2007) 2481-2495
7. Hashimoto K. Reply to: Minocycline, schizophrenia and GluR1 glutamate receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009) 167
8. Hashimoto K. Minocycline as a therapeutic drug for methamphetamine use disorders. Nihon Shinkei Seishin Yakurigaku Zasshi 28 (2008) 19-22
9. Hashimoto K., Tsukada H., Nishiyama S., Fukumoto D., Kakiuchi T., and Iyo M. Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys. Biol. Psychiatry 61 (2007) 577-581
10. Hutchinson M.R., Northcutt A.L., Chao L.W., Kearney J.J., Zhang Y., Berkelhammer D.L., Loram L.C., Rozeske R.R., Bland S.T., Maier S.F., Gleeson T.T., and Watkins L.R. Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav. Immun. 22 (2008) 1248-1256
11. Imbesi M., Uz T., Manev R., Sharma R.P., and Manev H. Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors. Neurosci. Lett. 447 (2008) 134-137
12. Kim H.S., and Suh Y.H. Minocycline and neurodegenerative diseases. Behav. Brain Res. 196 (2009) 168-179
13. Kofman O., van Embden S., Alpert C., and Fuchs I. Central and peripheral minocycline suppresses motor activity in rats. Pharmacol. Biochem. Behav. 44 (1993) 397-402
14. Mika J., Wawrzczak-Bargiela A., Osikowicz M., Makuch W., and Przewlocka B. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain Behav. Immun. 23 (2009) 75-84
15. Miyaoka T., Yasukawa R., Yasuda H., Hayashida M., Inagaki T., and Horiguchi J. Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin. Neuropharmacol. 31 (2008) 287-292
16. Mizoguchi H., Takuma K., Fukakusa A., Ito Y., Nakatani A., Ibi D., Kim H.C., and Yamada K. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology (Berl.) 196 (2008) 233-241
17. Molina-Hernández M., Tellez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., and Jaramillo-Jaimes M.T. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 380-386
18. Molina-Hernández M., Téllez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., and Jaramillo-Jaimes M.T. Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 1660-1666
19. Palmer C.L., Cotton L., and Henley J.M. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol. Rev. 57 (2005) 253-277
20. Prinssen E.P., Kleven M.S., Vignon J., Kamenka J.M., and Koek W. Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice. J. Pharmacol. Exp. Ther. 276 (1996) 904-911
21. Song Y., Wei E.Q., Zhang W.P., Ge Q.F., Liu J.R., Wang M.L., Huang X.J., Hu X., and Chen Z. Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation. Brain Res. 1085 (2006) 57-67
22. Uz T., Akhisaroglu M., Ahmed R., and Manev H. The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice. Neuropsychopharmacology 28 (2003) 2117-2123
23. Zhang L., Kitaichi K., Fujimoto Y., Nakayama H., Shimizu E., Iyo M., and Hashimoto K. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1381-1393
24. Zhang L., Shirayama Y., Iyo M., and Hashimoto K. Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology 32 (2007) 2004-2010
25. Zhang L., Shirayama Y., Shimizu E., Iyo M., and Hashimoto K. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Eur. J. Pharmacol. 544 (2006) 1-9